Insulin resistance may go undetected in non- diabetics with Parkinson’s

Washington DC: A new research has found that the resistance to insulin amongst non- diabetic patients with Parkinson’s Disease ( PD) is a common yet largely undetected problem. Reduced glucose tolerance has long been recognised as a potential risk factor for PD, and there is increasing scrutiny of insulin resistance as a pathologic driver of neurodegeneration. The key link between the two conditions appears to be insulin resistance, a potentially reversible condition that not only predisposes individuals to type2 diabetes ( DM2) but is also associated with neuro degeneration. However, the prevalence of insulin resistance in PD is unknown. A researcher, Michele Tagliati, said, “There is growing interest in the study of this relationship and the use of diabetes medications in the treatment of PD. However, there is little information regarding the prevalence of insulin resistance in PD.” “This study is the first to address this question in a large population of non- diabetic patients,” Tagliati added. Researchers ran tests on 154 non- diabetic PD patients for fasting blood sugar and insulin to assess the prevalence of insulin resistance and to correlate insulin resistance with other metabolic indicators, motor and non- motor symptoms of PD, and quality of life. Results revealed that nearly two- thirds of patients ( 58.4%) had undiagnosed insulin resistance, despite normal fasting glucose and, in many cases, normal hemoglobin A1c ( HbA1c), a test that is regularly conducted for diagnosing type- 1 and type- 2 diabetes. — ANI